Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

Related Articles by Review for PubMed (Select 12785411)

1.

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM; SHEA.

Infect Control Hosp Epidemiol. 2003 May;24(5):362-86. Review.

PMID:
12785411
2.

Can antibiotic-resistant nosocomial infections be controlled?

Farr BM, Salgado CD, Karchmer TB, Sherertz RJ.

Lancet Infect Dis. 2001 Aug;1(1):38-45. Review.

PMID:
11871409
3.
4.

Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.

Henderson DK.

Am J Infect Control. 2006 Jun;34(5 Suppl 1):S46-54: discussion S64-73. Review.

PMID:
16813982
6.

Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.

Henderson DK.

Am J Med. 2006 Jun;119(6 Suppl 1):S45-52; discussion S62-70. Review.

PMID:
16735151
7.

Prevention and control of methicillin-resistant Staphylococcus aureus infections.

Farr BM.

Curr Opin Infect Dis. 2004 Aug;17(4):317-22. Review.

PMID:
15241075
8.

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: recognition and prevention in intensive care units.

Lin MY, Hayden MK.

Crit Care Med. 2010 Aug;38(8 Suppl):S335-44. doi: 10.1097/CCM.0b013e3181e6ab12. Review.

PMID:
20647791
9.

Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition.

Ajao AO, Harris AD, Roghmann MC, Johnson JK, Zhan M, McGregor JC, Furuno JP.

Infect Control Hosp Epidemiol. 2011 May;32(5):481-9. doi: 10.1086/659403. Review.

10.

Vancomycin-resistant enterococci (VRE): transmission and control.

Tacconelli E, Cataldo MA.

Int J Antimicrob Agents. 2008 Feb;31(2):99-106. doi: 10.1016/j.ijantimicag.2007.08.026. Epub 2007 Dec 31. Review.

PMID:
18164908
11.
12.

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare.

Calfee DP.

Curr Opin Infect Dis. 2012 Aug;25(4):385-94. doi: 10.1097/QCO.0b013e3283553441. Review.

PMID:
22614523
13.
14.

Control of methicillin-resistant Staphylococcus aureus in the hospital setting.

Herwaldt LA.

Am J Med. 1999 May 3;106(5A):11S-18S; discussion 48S-52S. Review.

PMID:
10348059
15.

5 Million Lives Campaign. Reducing methicillin-resistant Staphylococcus aureus (MRSA) infections.

Griffin FA.

Jt Comm J Qual Patient Saf. 2007 Dec;33(12):726-31. Review.

PMID:
18200897
16.

Highly virulent pathogens--a post antibiotic era?

Domin MA.

Br J Theatre Nurs. 1998 May;8(2):14-8. Review.

PMID:
9677888
17.

Vancomycin-resistant enterococci: consequences for therapy and infection control.

Mascini EM, Bonten MJ.

Clin Microbiol Infect. 2005 Jul;11 Suppl 4:43-56. Review.

PMID:
15953021
18.

Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen.

Martin MA.

Curr Clin Top Infect Dis. 1994;14:170-91. Review.

PMID:
8086114
19.

Screening and isolation for infection control.

Tacconelli E.

J Hosp Infect. 2009 Dec;73(4):371-7. doi: 10.1016/j.jhin.2009.05.002. Epub 2009 Aug 21. Review.

PMID:
19699554
20.

Clinical impact of vancomycin-resistant enterococci.

Patel R.

J Antimicrob Chemother. 2003 Jun;51 Suppl 3:iii13-21. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk